Validation study of a screening test for pancreatic cancer based on highly sensitive detection of gene mutations in duodenal juice collected by a specially-made catheter during gastrointestinal endoscopy after stimulation with synthetic human secretin

Yachida Shinichi0 个研究点目标入组 150 人开始时间: 2021年1月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patient-provided informed consent and over 20 years old
•2. Patients with pancreatic cancer or suspected of pancreatic cancer (N=100) and Participants without pancreatic cancer or other cancers (N=50) (Planned endoscopy)
•3. Persons who have given their written consent to participate in this research

•1) Patients with hypersensitivity to secretin or other ingredients (excipients: cysteine hydrochloride and mannitol)
•2) Patients in remission from acute pancreatitis or acute exacerbations of chronic pancreatitis within 2 weeks of the start of administration of the study drug
•3) Patients who don't discontinue anticholinergic drugs at least 5 half-lives prior to the start of administration of the study drug
•4) Pregnant or lactating women
•5) Patients who received other research drugs or investigational drugs within 3 months of the start of administration of the study drug
•6) Patients whom the doctor in charge judges inappropriate

发起方

Yachida Shinichi